扬农化工 20260226 摘要 税务总局政策调整或致农药出口结构性变化，2026 年 4 月起部分农药 及中间体出口退税取消，或刺激 2026 年一季度"抢出口"需求，短期 提振农药需求。 草甘膦、草铵膦等农药品种虽价格未明显上涨，但库存已偏紧，开工率 高企。草铵膦行业经历内卷后，库存低位，开工率超 90%，3-4 月或迎 涨价窗口。 2025 年以来，农药行业资本扩张放缓，新增产能减少。行业协会倡导 规范生产，安全监管趋严，或加速存量产能优化与出清，供给端约束有 望强化。 扬农化工在行业下行周期展现经营韧性，2024 年利润约 12 亿元。江苏 优嘉基地盈利能力强劲，2024 年及 2025 年上半年净利率超 15%，体 现先进制造优势。 扬农化工中长期增长动力来自葫芦岛基地，一期资本开支约 35 亿元， 分两阶段投产。一阶段已基本满产，二阶段 2026 年进入放量期，目前 已满产产品均盈利。 Q&A 2026 年一季度农药行业需求端出现了哪些边际变化，出口退税政策调整对需 求节奏可能带来怎样的影响？ 从季节性看，春节后下游通常存在较为明显的补库行为，春季本身属于农药需 求旺季。2026 年相较往年存在额 ...

农药涨价品种及龙头企业分析 20260226 摘要 烯草酮和氯虫苯甲酰胺因供给侧冲击在 2025 年价格显著上涨，而草甘 膦作为代表性除草剂，价格年内波动后回落，后续价格受海外政策和国 内供给约束影响，预计有望回升至 26,000 元左右。 2025 年农药行业供需错配突出，吡虫啉等品种因扩产导致结构性过剩， 丙硫菌唑与戊唑醇等杀菌剂设计产能持续超过市场需求，整体价格承压。 2026 年初连续安全事故促使监管层加强对农化市场治理和产能控制的 决心，预计 2026 年明确方向与目标，2027 年进入实质执行阶段，销 售收入 10 亿元以下的企业面临更大压力。 草铵膦价格已大幅下降，主要由于供给端扩产，即使上涨，空间也有限。 烯草酮在 2025 年已大幅上涨，阿维菌素预计仍可缓慢上涨，甲维盐受 专利约束影响，2026 年价格或将继续上涨。 高效氯氟氰菊酯与氯氟氰菊酯价格处于近十年低位，价格能否上行取决 于后续产能控制能否落地。麦草畏短期判断价格有望上涨 1 万以上至 9 万，长期看可到 10 万。 Q&A 2025 年农药行业整体供需与价格表现如何，哪些品种出现了显著涨价，背后 的驱动因素是什么？ 2025 年中 ...

Core Viewpoint - The company, a leading player in the domestic pesticide industry, is expected to benefit from the gradual recovery of pesticide prices and the ramp-up of its Youchuang project, leading to potential growth in both volume and price [1][4]. Group 1: Company Overview - The company, established in 1999 and backed by Syngenta Group, is a top-tier player in the agricultural chemical sector in China, specializing in pyrethroid active ingredients [2]. - It is a core supplier of pyrethroid products globally, with a comprehensive product range including insecticides, herbicides, fungicides, and plant growth regulators, achieving a total production capacity exceeding 100,000 tons [2][4]. - The company has nearly 70 varieties of active ingredients and anticipates production and sales of raw materials to reach 96,913.34 tons and 99,872.64 tons respectively in 2024, reflecting year-on-year growth of 6.67% and 3.50% [2]. Group 2: Market Dynamics - The pesticide market is experiencing a supply-demand optimization, with prices stabilizing and rebounding after significant declines since 2022 [3]. - The agricultural price index has shown a recovery trend, with the raw material index reflecting improvements in various categories, including herbicides [3]. - The implementation of stricter regulations, such as the "one product, one certificate" policy, is expected to benefit leading companies with abundant registration certificates [3]. Group 3: Project Developments - The Youchuang project is set to enhance production capacity, increasing the output of high-efficiency chlorfenapyr from 5,500 tons/year to 8,500 tons/year, thereby solidifying the company's position in the pyrethroid market [1][3]. - The company is also advancing a technical transformation project for 3,000 tons of pyrazole ester, which is expected to contribute additional revenue [3]. Group 4: Financial Outlook - The company is projected to achieve a compound annual growth rate (CAGR) of 13.86% in net profit attributable to shareholders over the next three years, with a target price of 84.70 yuan based on a 22x PE ratio for 2026 [4].

Group 1: Company Operations and Production - The relocation of the company's riverside plant has been completed, with nine new raw material production facilities now fully operational, achieving an annual production capacity of over 10,000 tons [2] - The company has a supporting production line for 4,000 tons/year of benzoic acid methyl ester, and price fluctuations of this intermediate have minimal impact on the company's pyrethroid production line [2][3] - In 2025, the company expects significant growth in performance compared to the previous year, driven by internal efficiency improvements, technological advancements, and enhanced management practices [2][3] Group 2: Financial Performance and Market Trends - The production cost in the new plant is lower than that of the old facility, contributing to improved profit margins from high-gross-margin products [3] - The company has seen an increase in exports to the U.S. despite high tariff levels, with exports growing compared to the same period last year [3] - The sales of glyphosate have increased as overseas market inventories return to normal levels, although prices remain low, the profitability of this product has improved [3] Group 3: Regulatory Impact and Market Strategy - The upcoming "one certificate, one product" policy in 2026 is expected to benefit leading pesticide companies by enhancing product quality and brand differentiation in the market [3] - The company has adhered to information disclosure regulations during investor communications, ensuring no significant undisclosed information was leaked [3]

Group 1 - The core point of the article is that Changqing Co., Ltd. (002391) has confirmed its annual production capacity of glyphosate is 8,000 tons, primarily for export [1]

Investment Rating - The report maintains a "Strong Buy" rating for Yangnong Chemical (600486) with a target price of 79.2 CNY per share [2][7]. Core Views - The agricultural chemical industry is gradually improving, and the company's performance in the off-season meets expectations. The company is expected to show strong earnings elasticity as the agricultural chemical cycle begins to recover [2][7]. - The company's revenue for the first three quarters of 2025 reached 9.156 billion CNY, a year-on-year increase of 14.23%, while the net profit attributable to the parent company was 1.055 billion CNY, up 2.88% year-on-year [7][8]. - The report highlights the steady growth in raw material sales and an increase in glyphosate prices, indicating a positive trend in the agricultural chemical market [7][8]. Financial Summary - **Revenue Forecast**: Total revenue is projected to be 10.435 billion CNY in 2024, increasing to 12.702 billion CNY in 2025, with a year-on-year growth rate of 21.7% [3][8]. - **Net Profit Forecast**: The net profit attributable to the parent company is expected to be 1.202 billion CNY in 2024, with a slight increase to 1.267 billion CNY in 2025, reflecting a growth rate of 5.4% [3][8]. - **Earnings Per Share (EPS)**: EPS is forecasted to be 2.97 CNY in 2024, increasing to 3.13 CNY in 2025 [3][8]. - **Valuation Ratios**: The price-to-earnings (P/E) ratio is projected to decrease from 22 in 2024 to 21 in 2025, and further down to 16 in 2026 [3][8]. Market Performance - The report notes a significant recovery in agricultural chemical exports, with a 17.63% increase in export value from January to September 2025, particularly in insecticides, fungicides, and herbicides [7][8]. - The company is advancing its Huludao project, which is expected to contribute to sustained growth and profitability as production ramps up [7][8].

Investment Rating - The report maintains an "Accumulate" investment rating for the company [4][7]. Core Views - The company's performance in the first three quarters of 2025 showed a slight year-on-year increase, with revenue reaching 9.156 billion yuan, up 14.23%, and net profit attributable to shareholders at 1.055 billion yuan, up 2.88% [1]. - The agricultural chemical industry is expected to reach a bottom and recover, despite ongoing challenges such as geopolitical issues and market competition [7]. - The company has successfully increased its raw material sales and is focusing on cost reduction and efficiency improvements to mitigate adverse impacts [7]. Financial Data and Valuation - Revenue projections for the company from 2023 to 2027 are as follows: 11.478 billion yuan in 2023, 10.435 billion yuan in 2024, 11.925 billion yuan in 2025, 13.567 billion yuan in 2026, and 15.331 billion yuan in 2027, with a projected growth rate of 14% in 2025 [3][14]. - The expected net profit for 2025 is 1.232 billion yuan, with earnings per share (EPS) projected at 3.04 yuan [3][15]. - The current price-to-earnings (PE) ratio is estimated to be 21 times for 2025, decreasing to 15 times by 2027 [7][8]. Company Performance - The company's raw material revenue for the first three quarters was 5.41 billion yuan, a 12.2% increase year-on-year, while formulation revenue was 1.32 billion yuan, a 4.6% decrease [7]. - The average selling price of raw materials decreased by 1.12%, while the average selling price of formulations fell by 1.61% [7]. - The company is focusing on technological innovation and has made significant progress in new project construction, particularly in the production of pyrethroid products [7].

Core Viewpoint - The continuous expansion of crop planting area in China is driving the growth of the herbicide market, with increasing demand for long-lasting herbicides in non-agricultural sectors such as railways and industrial parks, leading companies to develop environmentally friendly formulations with a duration of over six months [1][9]. Summary by Sections Overview - The herbicide market is defined under the revised "Pesticide Management Regulations" by the State Council, which categorizes herbicides as substances used to suppress or kill weeds, thereby protecting crops [2]. - There are over 300 types of herbicides, classified into thirteen categories based on their chemical structure [2]. Industry Chain - The upstream of the herbicide industry includes suppliers of petrochemical raw materials, inorganic chemicals, and production equipment, while the midstream consists of glyphosate processing enterprises, and the downstream primarily serves agricultural and non-agricultural weed control markets [7][8]. Current Development - The total production of agricultural raw materials in China is projected to reach 3.3126 million tons in 2024, with herbicides accounting for 1.2719 million tons, representing 38.40% of the total [1][9]. - The demand for herbicides is expected to grow due to the continuous increase in crop planting area, which reached 173 million hectares in 2024, with various crops showing positive growth rates [8]. Import and Export Trade - In 2024, China's herbicide exports are expected to reach 2.1244 million tons, generating an export revenue of approximately $5.085 billion, with retail packaging accounting for 57.21% of the exports [10]. Competitive Landscape - The herbicide market in China is characterized by the coexistence of domestic and foreign companies, with leading firms like Bayer, Syngenta, and BASF holding significant market shares, while domestic companies such as Adama, Xingfa Group, and New Hope Group have also enhanced their market competitiveness [11]. Key Companies - Adama's revenue in 2024 is projected to exceed 29.49 billion yuan, with herbicide sales contributing 39.77% of its total revenue [11]. - New Hope Group is expected to achieve a revenue of 14.67 billion yuan in 2024, with a gross profit margin of 11.07% [12]. Future Trends - The future of the herbicide industry may see the integration of drone technology for real-time weed monitoring and targeted application, as well as a shift towards a closed-loop ecosystem that encompasses research, production, service, and recycling [13].

Group 1: Financial Performance - In the first half of 2025, the company achieved revenue of 6.234 billion yuan, a year-on-year increase of 9.38% [1] - The net profit attributable to shareholders was 806 million yuan, up 5.60% year-on-year, while the net profit excluding non-recurring items was 796 million yuan, increasing by 7.86% [1] - In Q2 2025, the company reported revenue of 2.993 billion yuan, a year-on-year growth of 18.63% but a quarter-on-quarter decline of 7.64% [1] Group 2: Product Pricing and Sales - The average selling prices for raw materials and formulations in H1 2025 were 64,500 yuan/ton and 41,600 yuan/ton, down 3.04% and 2.89% year-on-year, respectively [2] - Sales volumes for raw materials and formulations were 56,700 tons and 28,100 tons, reflecting increases of 13.43% and 0.12% year-on-year [2] - The market prices for key products in Q2 2025 showed mixed trends, with glyphosate at 23,400 yuan/ton (down 8.72% year-on-year) and other products experiencing various percentage changes [2] Group 3: Industry Trends - The agricultural chemical industry is showing signs of stabilization, with a 10% year-on-year increase in pesticide production in China during the first half of 2025 [3] - China's pesticide exports reached 1.806 million tons in H1 2025, a year-on-year increase of 15.72%, with export value rising to 4.902 billion USD, up 13.38% [3] - The market prices for major products as of August 23, 2025, showed varying changes compared to the beginning of the year, with glyphosate increasing by 13.95% [3] Group 4: Project Developments - The Huludao project is progressing rapidly, focusing on the production of insecticides, fungicides, herbicides, and related intermediates, with an annual capacity of 15,650 tons of pesticide raw materials [4] - The first phase of the project has been fully operational, while the second phase began trial production in July 2025 [4] - A subsidiary is expected to commence production of 3,000 tons of pyrazole ester and 22,665 tons of by-products in Q3 2025 [4] Group 5: Investment Outlook - The company forecasts net profits attributable to shareholders of 1.412 billion, 1.665 billion, and 2.027 billion yuan for 2025, 2026, and 2027, respectively, with corresponding PE ratios of 21, 18, and 15 times [5]

Group 1 - The report addresses key issues such as tracking downstream formulation inventory data and grain crop prices to assess the recovery of pesticide demand and the bottoming out of the cycle [1] - The demand for pesticides is recovering as terminal inventory decreases and grain prices stabilize, with raw material prices reaching a bottom [1] - By the end of 2024, inventory amounts and ratios for major agricultural chemical companies are expected to decline significantly [1] Group 2 - The company has a solid bottom-line profit with a CAGR of 17% in revenue and 19% in net profit from 2002 to 2024 [2] - The company is a leader in the domestic pyrethroid market, with significant advantages in the integrated supply chain [2] - The Yujia factory achieved revenue of 4.94 billion yuan and a net profit of 770 million yuan in 2024, with a net profit margin of 15.6% [2] Group 3 - The company has established a leading pesticide innovation platform through independent research and collaboration with Syngenta [3] - The company is expected to see significant revenue growth, with projected revenues of 12.8 billion, 14.7 billion, and 16.4 billion yuan for 2025, 2026, and 2027 respectively [3] - The company maintains a "buy" rating based on the progress of the Huludao project, which is expected to drive a new growth phase [3]